SlideShare a Scribd company logo
1 of 17
COVID- 19
BY: SANKET BALID
FINAL YEAR BPHARM
ALARD COLLEGE OF PHARMACY
INTRODUCTION
▪ Virus, infectious agent of small size and simple composition that can multiply only in
living cells of animals, plants, or bacteria. The name is from a Latin word meaning “slimy
liquid” or “poison.”
▪ Viruses occupy a special taxonomic position: they are not plants, animals,
or prokaryotic bacteria (single-cell organisms without defined nuclei), and they are
generally placed in their own kingdom. In fact, viruses should not even be considered
organisms, in the strictest sense, because they are not free-living—i.e., they cannot
reproduce and carry on metabolic processes without a host cell.
At the end of 2019, a series of pneumonia cases of unknown cause emerged in Wuhan (Hubei,
China). A few weeks later, in January 2020, deep sequencing analysis from lower respiratory tract
samples identified a novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as
causative agent for that observed pneumonia cluster.
On February 11th, 2020, the World Health Organization (WHO) Director-General, Dr. Tedros
Adhanom Ghebreyesus, named the disease caused by the SARS-CoV-2 as “COVID-19”, and by March
11th, 2020 when the number of countries involvedwas 114, with more than 118,000 cases and
over 4000 deaths, the WHO declared the pandemic status
General information on the virus
▪ Coronaviruses are a group of related viruse that cause diseases in mammals and birds In humans, coronaviruses
cause respiratory tract infections that can range from mild to lethal. Mild illnesses include some cases of
the common cold (which has other possible causes, predominantly rhinoviruses), while more lethal varieties can
cause SARS, MERS, and COVID-19
▪ Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae, order Nidovirales, and
realm Riboviria. They are enveloped viruses with a positive-sense single-stranded RNA genome and
a nucleocapsid of helical symmetry. The genome size of coronaviruses ranges from approximately 26 to
32 kilobases, one of the largest among RNA viruses. They have characteristic club-shaped spikes that project
from their surface, which in electron micrographs create an image reminiscent of the so corona from which their
name derives.
STRUCTURE
▪ Coronaviruses are large pleomorphic spherical particles with bulbous surface
projections.The average diameter of the virus particles is around 120 nm(.12 μm).
The diameter of the envelope is ~80 nm (.08 μm) and the spike are ~20 nm (.02
μm) long. The envelope of the virus in electron micrographs appears as a distinct pair
of electron dense shells.
▪ The viral envelop consists of a lipid bilayer where the membrane (M), envelope € and
spike (S) structural proteins are anchored. A subset of coronaviruses (specifically the
members of beta coronavirus subgroup A also have a shorter spike-like surface
protein called hemagglutinin esterase (HE)
▪ Inside the envelope, there is the nucleocapsid, which is formed from multiple copies
of the nucleocapsid (N) protein, which are bound to the positive-sense single-
stranded RNA genome in a continuous beads-on-a-strin type conformation. The lipid
bilayer envelope, membrane proteins, and nucleocapsid protect the virus when it is
outside the host cell.
STRUCTURE
Illustration of the morphology of
coronaviruses; the club-shaped viral spike
peplomers, colored red, create the look of
a corona surrounding the virion when
observed with an electron microscope
COVID 19:
DISEASE CAUSED BY NOVEL CORONA VIRUS
SIGNS AND SYMPTOMS
COVID-19-associated symptoms.
▪ Fever
▪ Cough
▪ Dyspnea
▪ Headach
▪ Sore throat
▪ Rhinorrhea
DIAGNOSIS
For patients with suspected infection, the following diagnosis techniques are utilised:
performing real-time fluorescence (RT-PCR) to detect the positive nucleic acid of SARS-CoV-
2 in sputum, throat swabs, and secretions of the lower respiratory tract samples.
In patients with COVID-19, the white blood cell count can vary. Leukopenia, leukocytosis,
and lymphopenia have been reported, although lymphopenia appears most common
Elevated lactate dehydrogenase and ferritin levels are common, and elevated
aminotransferase levels have also been described.
Management
There is no specific antiviral treatment recommended for COVID-19, and no vaccine is currently
available. The treatment is symptomatic, and oxygen therapy represents the major treatment
intervention for patients with severe infection. Mechanical ventilation may be necessary in cases
of respiratory failure refractory to oxygen therapy, whereas hemodynamic support is essential for
managing septic shock.
Different strategies can be used depending on the severity of the patient
and local epidemiology. Home management is appropriate for asymptomatic or paucisymptomatic
patients. They need a daily assessment of body temperature, blood pressure, oxygen saturation and
respiratory symptoms for about 14 days.
Management of such patients should focus on prevention of transmission to others and
monitoring for clinical status with prompt hospitalization if needed. They should wear a
face mask when in the same room (or vehicle) as other people and when presenting to
health care settings. Disinfection of frequently touched surfaces is also important
Outpatients with COVID-19 should stay at home and try to separate themselves from other
people in the household. On admission, many patients with pneumonia have normal serum
procalcitonin levels; however, in those requiring ICU care, they are more likely to be
elevated. High D-dimer levels and more severe lymphopenia have been associated with
mortality. Imaging findings—Chest computed tomography (CT) in patients with COVID-19
most commonly demonstrates ground-glass opacification with or without consolidative
abnormalities,
Management ContinuedChloroquine and hydroxychloroquine have antiviral activity in vitro, as well as anti-
inflammatory activities.
They act on interference with the cellular receptor ACE2, on impairment of acidification of
endosomes and on activity against many pro-inflammatory cytokines (e.g., IL-1 and IL-6)
Tocilizumab is a recombinant humanized monoclonal antibody which binds to the
interleukin-6 (IL-6) receptor and blocks it from functioning.
It is used for patients with severe COVID-19 and elevated IL-6 levels; the agent is being
evaluated in a clinical trial
Prevention of COVID 19
• Clean your hands often. Use soap
and water, or an alcohol-based
hand rub.
• Maintain a safe distance from
anyone who is coughing or
sneezing.
• Don’t touch your eyes, nose or
mouth.
• Cover your nose and mouth with
your bent elbow or a tissue when
you cough or sneeze.
• Stay home if you feel unwell.
• If you have a fever, a cough, and
difficulty breathing, seek medical
attention. Call in advance.
• Follow the directions of your local
health authority.
घरी
राहा
खा
प्या
झोप
घ्या
STAY HOME
AND
STAY SAFE
घरी रहा
आणि
सुरक्षित रहा
Conclusion
▪ As there is no proper treatment and vaccine for COVID 19 it is
advisable to stay home and stay safe. Together we can and we will
conquer this pandemic by cooperating with the Government of
respective countries by avoiding social gatherings.
▪ Use Masks, and sanitizers while going out to by groceries,
medicines, etc.
▪ And most importantly avoid hand shakes and maintain social
distancing.
THERE’S NOTHING TO FEAR FOLLOW THESE THINGS AND SPEND
QUALITY TIME WITH FAMILY AND LOVED ONES
THANK YOU
SUPPORT THE GOVERNMENT AND LOCAL HEALTH AUTHORITIES

More Related Content

What's hot

Pathogenesis of bacterial infection and nosocomial infection
Pathogenesis of bacterial infection and nosocomial infectionPathogenesis of bacterial infection and nosocomial infection
Pathogenesis of bacterial infection and nosocomial infectionRegi Septian
 
Icu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket GeeteIcu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket GeeteAniket Geete
 
Corona virus and hbs.dr quiyum
Corona virus and hbs.dr quiyumCorona virus and hbs.dr quiyum
Corona virus and hbs.dr quiyumMD Quiyumm
 
SW Biotechnology pack
SW Biotechnology packSW Biotechnology pack
SW Biotechnology packRichard Male
 
Hospital acquired infection
Hospital acquired     infectionHospital acquired     infection
Hospital acquired infectionKashif Khokhar
 
Isyaku aminu pesentation (1)
Isyaku aminu pesentation (1)Isyaku aminu pesentation (1)
Isyaku aminu pesentation (1)aminu isyaku
 
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Arun Singh
 
Nosocomial Infection
Nosocomial InfectionNosocomial Infection
Nosocomial InfectionZahoor Ahmed
 
Evidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patientsEvidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patientsSaren Azer
 

What's hot (17)

Pathogenesis of bacterial infection and nosocomial infection
Pathogenesis of bacterial infection and nosocomial infectionPathogenesis of bacterial infection and nosocomial infection
Pathogenesis of bacterial infection and nosocomial infection
 
Teaching infection toStudetns by Dr.T.V.Rao MD
Teaching infection toStudetns by Dr.T.V.Rao MDTeaching infection toStudetns by Dr.T.V.Rao MD
Teaching infection toStudetns by Dr.T.V.Rao MD
 
Icu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket GeeteIcu infection and its medical management by Dr. Aniket Geete
Icu infection and its medical management by Dr. Aniket Geete
 
Corona virus and hbs.dr quiyum
Corona virus and hbs.dr quiyumCorona virus and hbs.dr quiyum
Corona virus and hbs.dr quiyum
 
SW Biotechnology pack
SW Biotechnology packSW Biotechnology pack
SW Biotechnology pack
 
Hospital acquired infection
Hospital acquired     infectionHospital acquired     infection
Hospital acquired infection
 
Isyaku aminu pesentation (1)
Isyaku aminu pesentation (1)Isyaku aminu pesentation (1)
Isyaku aminu pesentation (1)
 
HOSPITAL ASSOCIATED INFECTIONS ROLE OF RESIDENT DOCTORS
HOSPITAL ASSOCIATED INFECTIONS ROLE OF RESIDENT DOCTORS�HOSPITAL ASSOCIATED INFECTIONS ROLE OF RESIDENT DOCTORS�
HOSPITAL ASSOCIATED INFECTIONS ROLE OF RESIDENT DOCTORS
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infections
 
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
 
Infection in critical care
Infection in critical careInfection in critical care
Infection in critical care
 
Nosocomial Infection
Nosocomial InfectionNosocomial Infection
Nosocomial Infection
 
Covid19 by likhit
Covid19  by likhitCovid19  by likhit
Covid19 by likhit
 
Coronavirus
CoronavirusCoronavirus
Coronavirus
 
Coronavirus disease
Coronavirus diseaseCoronavirus disease
Coronavirus disease
 
7th issue of CRC HKL Newsletter 2020
7th issue of CRC HKL Newsletter 20207th issue of CRC HKL Newsletter 2020
7th issue of CRC HKL Newsletter 2020
 
Evidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patientsEvidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patients
 

Similar to Covid 19

Novel coronavirus (covid-19) A Pandemic disease
Novel coronavirus (covid-19) A Pandemic disease Novel coronavirus (covid-19) A Pandemic disease
Novel coronavirus (covid-19) A Pandemic disease KarunaRaghuwanshi1
 
Novel Coronavirus COVID-19
Novel Coronavirus COVID-19Novel Coronavirus COVID-19
Novel Coronavirus COVID-19Avinandan Jana
 
Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...
Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...
Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...sagapolarajini
 
Covid 19 disease information ppt
Covid 19 disease information pptCovid 19 disease information ppt
Covid 19 disease information pptsrinivas boddepalli
 
The novel coronavirus disease 2019 (covid 19)overview
The novel  coronavirus disease 2019 (covid 19)overviewThe novel  coronavirus disease 2019 (covid 19)overview
The novel coronavirus disease 2019 (covid 19)overviewMakrani Shaharukh
 
Cornovirus Microbiology and Management
Cornovirus Microbiology and Management Cornovirus Microbiology and Management
Cornovirus Microbiology and Management DrShrey Bhatia
 
Covid-19 according to CDC
Covid-19 according to CDCCovid-19 according to CDC
Covid-19 according to CDCREKHA DEHARIYA
 
Etiology and pathogenesis of covid 19
Etiology and pathogenesis of covid 19Etiology and pathogenesis of covid 19
Etiology and pathogenesis of covid 19dharmesh chaturvedi
 
PATHOLOGY OF COVID-19
PATHOLOGY OF COVID-19PATHOLOGY OF COVID-19
PATHOLOGY OF COVID-19DrRashmiBudha
 

Similar to Covid 19 (20)

Novel coronavirus (covid-19) A Pandemic disease
Novel coronavirus (covid-19) A Pandemic disease Novel coronavirus (covid-19) A Pandemic disease
Novel coronavirus (covid-19) A Pandemic disease
 
Covid 19 rajni sharma
Covid 19 rajni sharmaCovid 19 rajni sharma
Covid 19 rajni sharma
 
Corona virus
Corona virusCorona virus
Corona virus
 
Novel Coronavirus COVID-19
Novel Coronavirus COVID-19Novel Coronavirus COVID-19
Novel Coronavirus COVID-19
 
Human coronavirus By Dr K Selvakumar
Human coronavirus   By Dr K SelvakumarHuman coronavirus   By Dr K Selvakumar
Human coronavirus By Dr K Selvakumar
 
Covid 19 presentation
Covid 19  presentationCovid 19  presentation
Covid 19 presentation
 
Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...
Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...
Review on strategies to counteract sars cov-2 by anti-inflammatory and anti-o...
 
Covid 19, a brif study
Covid 19, a brif studyCovid 19, a brif study
Covid 19, a brif study
 
Clinical presentation of Covid 19
Clinical presentation of Covid 19Clinical presentation of Covid 19
Clinical presentation of Covid 19
 
Covid 19 disease information ppt
Covid 19 disease information pptCovid 19 disease information ppt
Covid 19 disease information ppt
 
Coronavirus disease
Coronavirus diseaseCoronavirus disease
Coronavirus disease
 
Coronavirus Disease (nCOV-19)
Coronavirus Disease (nCOV-19)Coronavirus Disease (nCOV-19)
Coronavirus Disease (nCOV-19)
 
The novel coronavirus disease 2019 (covid 19)overview
The novel  coronavirus disease 2019 (covid 19)overviewThe novel  coronavirus disease 2019 (covid 19)overview
The novel coronavirus disease 2019 (covid 19)overview
 
Cornovirus Microbiology and Management
Cornovirus Microbiology and Management Cornovirus Microbiology and Management
Cornovirus Microbiology and Management
 
Coronavirus (covid 19)
Coronavirus (covid 19)Coronavirus (covid 19)
Coronavirus (covid 19)
 
Corona virus
Corona virusCorona virus
Corona virus
 
Covid-19 according to CDC
Covid-19 according to CDCCovid-19 according to CDC
Covid-19 according to CDC
 
Etiology and pathogenesis of covid 19
Etiology and pathogenesis of covid 19Etiology and pathogenesis of covid 19
Etiology and pathogenesis of covid 19
 
PATHOLOGY OF COVID-19
PATHOLOGY OF COVID-19PATHOLOGY OF COVID-19
PATHOLOGY OF COVID-19
 
COVID-19
COVID-19COVID-19
COVID-19
 

Recently uploaded

Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxUnboundStockton
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerunnathinaik
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 

Recently uploaded (20)

Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Blooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docxBlooming Together_ Growing a Community Garden Worksheet.docx
Blooming Together_ Growing a Community Garden Worksheet.docx
 
internship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developerinternship ppt on smartinternz platform as salesforce developer
internship ppt on smartinternz platform as salesforce developer
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 

Covid 19

  • 1. COVID- 19 BY: SANKET BALID FINAL YEAR BPHARM ALARD COLLEGE OF PHARMACY
  • 2. INTRODUCTION ▪ Virus, infectious agent of small size and simple composition that can multiply only in living cells of animals, plants, or bacteria. The name is from a Latin word meaning “slimy liquid” or “poison.” ▪ Viruses occupy a special taxonomic position: they are not plants, animals, or prokaryotic bacteria (single-cell organisms without defined nuclei), and they are generally placed in their own kingdom. In fact, viruses should not even be considered organisms, in the strictest sense, because they are not free-living—i.e., they cannot reproduce and carry on metabolic processes without a host cell.
  • 3. At the end of 2019, a series of pneumonia cases of unknown cause emerged in Wuhan (Hubei, China). A few weeks later, in January 2020, deep sequencing analysis from lower respiratory tract samples identified a novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as causative agent for that observed pneumonia cluster. On February 11th, 2020, the World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, named the disease caused by the SARS-CoV-2 as “COVID-19”, and by March 11th, 2020 when the number of countries involvedwas 114, with more than 118,000 cases and over 4000 deaths, the WHO declared the pandemic status
  • 4. General information on the virus ▪ Coronaviruses are a group of related viruse that cause diseases in mammals and birds In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal. Mild illnesses include some cases of the common cold (which has other possible causes, predominantly rhinoviruses), while more lethal varieties can cause SARS, MERS, and COVID-19 ▪ Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae, order Nidovirales, and realm Riboviria. They are enveloped viruses with a positive-sense single-stranded RNA genome and a nucleocapsid of helical symmetry. The genome size of coronaviruses ranges from approximately 26 to 32 kilobases, one of the largest among RNA viruses. They have characteristic club-shaped spikes that project from their surface, which in electron micrographs create an image reminiscent of the so corona from which their name derives.
  • 5. STRUCTURE ▪ Coronaviruses are large pleomorphic spherical particles with bulbous surface projections.The average diameter of the virus particles is around 120 nm(.12 μm). The diameter of the envelope is ~80 nm (.08 μm) and the spike are ~20 nm (.02 μm) long. The envelope of the virus in electron micrographs appears as a distinct pair of electron dense shells. ▪ The viral envelop consists of a lipid bilayer where the membrane (M), envelope € and spike (S) structural proteins are anchored. A subset of coronaviruses (specifically the members of beta coronavirus subgroup A also have a shorter spike-like surface protein called hemagglutinin esterase (HE) ▪ Inside the envelope, there is the nucleocapsid, which is formed from multiple copies of the nucleocapsid (N) protein, which are bound to the positive-sense single- stranded RNA genome in a continuous beads-on-a-strin type conformation. The lipid bilayer envelope, membrane proteins, and nucleocapsid protect the virus when it is outside the host cell.
  • 6. STRUCTURE Illustration of the morphology of coronaviruses; the club-shaped viral spike peplomers, colored red, create the look of a corona surrounding the virion when observed with an electron microscope
  • 7. COVID 19: DISEASE CAUSED BY NOVEL CORONA VIRUS
  • 8. SIGNS AND SYMPTOMS COVID-19-associated symptoms. ▪ Fever ▪ Cough ▪ Dyspnea ▪ Headach ▪ Sore throat ▪ Rhinorrhea
  • 9. DIAGNOSIS For patients with suspected infection, the following diagnosis techniques are utilised: performing real-time fluorescence (RT-PCR) to detect the positive nucleic acid of SARS-CoV- 2 in sputum, throat swabs, and secretions of the lower respiratory tract samples. In patients with COVID-19, the white blood cell count can vary. Leukopenia, leukocytosis, and lymphopenia have been reported, although lymphopenia appears most common Elevated lactate dehydrogenase and ferritin levels are common, and elevated aminotransferase levels have also been described.
  • 10. Management There is no specific antiviral treatment recommended for COVID-19, and no vaccine is currently available. The treatment is symptomatic, and oxygen therapy represents the major treatment intervention for patients with severe infection. Mechanical ventilation may be necessary in cases of respiratory failure refractory to oxygen therapy, whereas hemodynamic support is essential for managing septic shock. Different strategies can be used depending on the severity of the patient and local epidemiology. Home management is appropriate for asymptomatic or paucisymptomatic patients. They need a daily assessment of body temperature, blood pressure, oxygen saturation and respiratory symptoms for about 14 days.
  • 11. Management of such patients should focus on prevention of transmission to others and monitoring for clinical status with prompt hospitalization if needed. They should wear a face mask when in the same room (or vehicle) as other people and when presenting to health care settings. Disinfection of frequently touched surfaces is also important Outpatients with COVID-19 should stay at home and try to separate themselves from other people in the household. On admission, many patients with pneumonia have normal serum procalcitonin levels; however, in those requiring ICU care, they are more likely to be elevated. High D-dimer levels and more severe lymphopenia have been associated with mortality. Imaging findings—Chest computed tomography (CT) in patients with COVID-19 most commonly demonstrates ground-glass opacification with or without consolidative abnormalities,
  • 12. Management ContinuedChloroquine and hydroxychloroquine have antiviral activity in vitro, as well as anti- inflammatory activities. They act on interference with the cellular receptor ACE2, on impairment of acidification of endosomes and on activity against many pro-inflammatory cytokines (e.g., IL-1 and IL-6) Tocilizumab is a recombinant humanized monoclonal antibody which binds to the interleukin-6 (IL-6) receptor and blocks it from functioning. It is used for patients with severe COVID-19 and elevated IL-6 levels; the agent is being evaluated in a clinical trial
  • 13.
  • 14. Prevention of COVID 19 • Clean your hands often. Use soap and water, or an alcohol-based hand rub. • Maintain a safe distance from anyone who is coughing or sneezing. • Don’t touch your eyes, nose or mouth. • Cover your nose and mouth with your bent elbow or a tissue when you cough or sneeze. • Stay home if you feel unwell. • If you have a fever, a cough, and difficulty breathing, seek medical attention. Call in advance. • Follow the directions of your local health authority.
  • 16. Conclusion ▪ As there is no proper treatment and vaccine for COVID 19 it is advisable to stay home and stay safe. Together we can and we will conquer this pandemic by cooperating with the Government of respective countries by avoiding social gatherings. ▪ Use Masks, and sanitizers while going out to by groceries, medicines, etc. ▪ And most importantly avoid hand shakes and maintain social distancing. THERE’S NOTHING TO FEAR FOLLOW THESE THINGS AND SPEND QUALITY TIME WITH FAMILY AND LOVED ONES
  • 17. THANK YOU SUPPORT THE GOVERNMENT AND LOCAL HEALTH AUTHORITIES